ENHANCE DIAGNOSTICS, INC.

Medtech · Private

A non-invasive exhaled breath test device that measures ammonia concentration to monitor blood ammonia levels in urea cycle disorder patients

Grants
$307K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Simple Breath Test for Ammonia for Monitoring Blood Ammonia Levels for UCD Patients$306,669
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
775OPTAVE DIAGNOSTICS LLC——
776Lalaith Astor Technical Consulting House, LLC——
777PhotoSonix Medical, Inc.—$410K
778ENHANCE DIAGNOSTICS, INC.——
779Alphyn Biologics, Inc.—$9.3M
780HEMOSHEAR LLC—$5.8M
781LUXEL CORPORATION——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.